Sept 29 (Reuters) - Irras AB IRRAS.ST :
* IRRAS ANNOUNCES RELEASE OF CLINICAL DATA THAT VALIDATES
SAFETY
AND EFFECTIVENESS OF IRRAFLOW SYSTEM IN TREATING CHRONIC
SUBDURAL HEMATOMAS
* NO COMPLICATIONS OR RECURRENCE OF BLEEDING SEEN DURING
PATIENT
TREATMENTS AT UNIVERSITY OF CALIFORNIA IRVINE
* RESEARCH SHOWED IRRAFLOW SAFELY TREATS SUBDURAL HEMATOMAS
WHILE
DECREASING COMPLICATIONS, BLEEDING RECURRENCE, AND LENGTH OF
HOSPITALIZATION
Source text for Eikon: ID:nWkr2XkGPh
Further company coverage: IRRAS.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))